EJCTS Click here to go to Edwards website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thelin, S.
Right arrow Articles by Thorelius, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thelin, S.
Right arrow Articles by Thorelius, J.

European Journal of Cardio-Thoracic Surgery, Vol 5, 486-491, Copyright © 1991 by European Association for Cardio-thoracic Surgery


ARTICLES

Heparin-coated cardiopulmonary bypass circuits reduce blood cell trauma. Experiments in the pig

S Thelin, L Bagge, J Hultman, J Borowiec, L Nilsson and J Thorelius
Department of Cardiovascular, University Hospital, Uppsala, Sweden.

Blood cell trauma and postoperative bleeding remain important problems in cardiopulmonary bypass (CPB). We compared heparin-coated with non- coated circuits in the pig. Twenty animals were perfused for 2 h at normothermia using membrane oxygenators (Bentley Bos 50). Two groups were studied. In the non-coated group (NC, n = 11) the CPB circuits used were without a heparin coating. This group had systemic heparinization of 400 IU/kg to maintain an ACT (activated clotting time) of over 400 s during CPB. In the coated group (C, n = 9), all surfaces exposed to blood in the CPB circuits were heparin-coated. This group had the heparin dose reduced to 25% (100 IU/kg) without further administration regardless of ACT. During CPB, group C displayed shorter ACT (per definition), higher platelet count, platelet adhesion and lower fibrinolysis and haemolysis (P less than 0.05) as compared to group NC. No thromboembolic events were detected during CPB. Three animals in group NC and 4 animals in group C were weaned from CPB and protaminized. Four hours postoperatively, the leucocyte consumption was two-fold greater and blood loss about four-fold greater in group NC as compared with group C (P less than 0.05). Perfusion with heparin-coated surfaces reduces blood cell trauma. The decreased postoperative blood loss observed in group C is probably explained by the reduced dosages of heparin and protamine.


This article has been cited by other articles:


Home page
Anesth. Analg.Home page
G. S. Murphy, E. A. Hessel II, and R. C. Groom
Optimal Perfusion During Cardiopulmonary Bypass: An Evidence-Based Approach
Anesth. Analg., May 1, 2009; 108(5): 1394 - 1417.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al.
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
Ann. Thorac. Surg., May 1, 2007; 83(5_Supplement): S27 - S86.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
H. P Wendel, A. M Scheule, F. S Eckstein, and G. Ziemer
Haemocompatibility of paediatric membrane oxygenators with heparin-coated surfaces
Perfusion, January 1, 1999; 14(1): 21 - 28.
[Abstract] [PDF]


Home page
PerfusionHome page
J. A. Hyde, J. A Chinn, and T. R Graham
Platelets and cardiopulmonary bypass
Perfusion, December 1, 1998; 13(6): 389 - 407.
[PDF]


Home page
Ann. Thorac. Surg.Home page
S. Bannan, A. Danby, D. Cowan, S. Ashraf, and P. G. Martin
Low Heparinization With Heparin-Bonded Bypass Circuits: Is It a Safe Strategy?
Ann. Thorac. Surg., March 1, 1997; 63(3): 663 - 668.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. D. Muehrcke, P. M. McCarthy, K. Kottke-Marchant, H. Harasaki, J. Pierre-Yared, J. A. Borsh, D. A. Ogella, and D. M. Cosgrove
BIOCOMPATIBILITY OF HEPARIN-COATED EXTRACORPOREAL BYPASS CIRCUITS: A RANDOMIZED, MASKED CLINICAL TRIAL
J. Thorac. Cardiovasc. Surg., August 1, 1996; 112(2): 472 - 483.
[Abstract] [Full Text]


Home page
CirculationHome page
E. Ovrum, F. Brosstad, E. Am Holen, G. Tangen, and M. Abdelnoor
Effects on Coagulation and Fibrinolysis With Reduced Versus Full Systemic Heparinization and Heparin-Coated Cardiopulmonary Bypass
Circulation, November 1, 1995; 92(9): 2579 - 2584.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
E. Ovrum, E. A. Holen, G. Tangen, F. Brosstad, M. Abdelnoor, M.-A. L. Ringdal, R. Oystese, and R. Istad
Completely Heparinized Cardiopulmonary Bypass and Reduced Systemic Heparin: Clinical and Hemostatic Effects
Ann. Thorac. Surg., August 1, 1995; 60(2): 365 - 371.
[Abstract] [Full Text]


Home page
PerfusionHome page
L. von Segesser, M. Pasic, M. Tonz, M. Lachat, B. Leskosek, and M. Turina
Use of an intravascular gas exchanger: is low systemic heparinization safe?
Perfusion, November 1, 1993; 8(6): 449 - 458.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1991 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.